| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 20108463
[patent_doc_number] => 12359172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Method for preparing 3D cartilage organoid block
[patent_app_type] => utility
[patent_app_number] => 16/067761
[patent_app_country] => US
[patent_app_date] => 2016-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067761 | Method for preparing 3D cartilage organoid block | Sep 30, 2016 | Issued |
Array
(
[id] => 13533633
[patent_doc_number] => 20180318359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/764275
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764275
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764275 | METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF ANIMALS | Sep 28, 2016 | Abandoned |
Array
(
[id] => 13904357
[patent_doc_number] => 20190041383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => METHOD FOR PREPARING SENESCENT MELANOCYTES, CELLS PREPARED BY METHOD, AND METHOD FOR SCREENING FOR SENESCENCE-ALLEVIATING MATERIAL BY USING CELLS
[patent_app_type] => utility
[patent_app_number] => 15/764615
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764615 | METHOD FOR PREPARING SENESCENT MELANOCYTES, CELLS PREPARED BY METHOD, AND METHOD FOR SCREENING FOR SENESCENCE-ALLEVIATING MATERIAL BY USING CELLS | Sep 28, 2016 | Abandoned |
Array
(
[id] => 16189358
[patent_doc_number] => 20200230207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => TREATMENT OF BONE GROWTH DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/763155
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763155 | TREATMENT OF BONE GROWTH DISORDERS | Sep 27, 2016 | Abandoned |
Array
(
[id] => 17513875
[patent_doc_number] => 11293008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Media for culturing epithelial cells
[patent_app_type] => utility
[patent_app_number] => 15/762517
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 5
[patent_no_of_words] => 10916
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762517 | Media for culturing epithelial cells | Sep 22, 2016 | Issued |
Array
(
[id] => 13955509
[patent_doc_number] => 20190054098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => AGENTS AND METHODS USING THEREOF FOR THE PREVENTION AND TREATMENT OF STEM CELLS SENESCENCE
[patent_app_type] => utility
[patent_app_number] => 15/758369
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758369 | AGENTS AND METHODS USING THEREOF FOR THE PREVENTION AND TREATMENT OF STEM CELLS SENESCENCE | Sep 6, 2016 | Abandoned |
Array
(
[id] => 13563777
[patent_doc_number] => 20180333436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE USING ROR1-POSITIVE MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 15/755859
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755859 | ROR1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ROR1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating disease using ROR1-positive mesenchymal stem cells | Aug 28, 2016 | Issued |
Array
(
[id] => 13793831
[patent_doc_number] => 20190010454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => Method for Culturing Limbal Stem Cells by Using Amniotic Membrane Slide Scaffold
[patent_app_type] => utility
[patent_app_number] => 16/066389
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066389
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066389 | Method for Culturing Limbal Stem Cells by Using Amniotic Membrane Slide Scaffold | Jul 21, 2016 | Pending |
Array
(
[id] => 16112301
[patent_doc_number] => 20200208173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => ADENOVIRUS CONTROL VIRUS
[patent_app_type] => utility
[patent_app_number] => 15/772301
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772301 | ADENOVIRUS CONTROL VIRUS | Jun 16, 2016 | Pending |
Array
(
[id] => 12857926
[patent_doc_number] => 20180177816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => THERAPEUTIC AGENT ASSOCIATED WITH SUPPRESSION OF PROLIFERATION AND METASTASIS OF TUMOR, WHICH COMPRISES EXOSOMES RELEASED FROM CYTOTOXIC T CELLS AND TARGETS CANCER STROMAL/MESENCHYMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 15/559771
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559771 | Therapeutic agent associated with suppression of proliferation and metastasis of tumor, which comprises exosomes released from cytotoxic T cells and targets cancer stromal/mesenchymal cells | Mar 17, 2016 | Issued |
Array
(
[id] => 13387063
[patent_doc_number] => 20180245073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
[patent_app_type] => utility
[patent_app_number] => 15/553021
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553021 | REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV) | Feb 22, 2016 | Abandoned |
Array
(
[id] => 14182905
[patent_doc_number] => 20190111157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => ENHANCED DELIVERY OF VIRAL PARTICLES TO THE STRIATUM AND CORTEX
[patent_app_type] => utility
[patent_app_number] => 15/549962
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549962
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549962 | ENHANCED DELIVERY OF VIRAL PARTICLES TO THE STRIATUM AND CORTEX | Feb 8, 2016 | Abandoned |
Array
(
[id] => 15290667
[patent_doc_number] => 20190388469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => PROTEIN DELIVERY IN PRIMARY HEMATOPOIETIC CELLS
[patent_app_type] => utility
[patent_app_number] => 15/547418
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547418
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547418 | PROTEIN DELIVERY IN PRIMARY HEMATOPOIETIC CELLS | Jan 28, 2016 | Pending |
Array
(
[id] => 12791617
[patent_doc_number] => 20180155708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => Split Cas9 Proteins
[patent_app_type] => utility
[patent_app_number] => 15/541859
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541859 | Split Cas9 Proteins | Jan 7, 2016 | Abandoned |
Array
(
[id] => 16189317
[patent_doc_number] => 20200230166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => Oligonucleotides in food, beverage, cosmetic and medicinal formulations
[patent_app_type] => utility
[patent_app_number] => 15/781357
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781357
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781357 | Oligonucleotides in food, beverage, cosmetic and medicinal formulations | Dec 2, 2015 | Abandoned |
Array
(
[id] => 12219479
[patent_doc_number] => 20180057839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/531341
[patent_app_country] => US
[patent_app_date] => 2015-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 39193
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531341 | THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME | Nov 26, 2015 | Pending |
Array
(
[id] => 14372399
[patent_doc_number] => 20190160112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => POPULATION OF AMNIOCYTES HAVING PHAGOCYTIC ACTIVITY AGAINST PATHOLOGICAL CELLS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF IN THE MEDICAL FIELD
[patent_app_type] => utility
[patent_app_number] => 15/777602
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777602 | POPULATION OF AMNIOCYTES HAVING PHAGOCYTIC ACTIVITY AGAINST PATHOLOGICAL CELLS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF IN THE MEDICAL FIELD | Nov 19, 2015 | Abandoned |
Array
(
[id] => 12092786
[patent_doc_number] => 20170349879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'METHOD FOR CULTURING NORMAL CELLS AND ODONTOMA CELLS CONTAINED IN ORAL TISSUE'
[patent_app_type] => utility
[patent_app_number] => 15/539107
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6154
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539107
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539107 | METHOD FOR CULTURING NORMAL CELLS AND ODONTOMA CELLS CONTAINED IN ORAL TISSUE | Jul 21, 2015 | Abandoned |
Array
(
[id] => 16909117
[patent_doc_number] => 11041146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Cell having ability to form stratified epithelial tissue, and method for producing same
[patent_app_type] => utility
[patent_app_number] => 15/523571
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12420
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523571 | Cell having ability to form stratified epithelial tissue, and method for producing same | Mar 29, 2015 | Issued |